ANRO logo

ANRO

Alto Neuroscience, Inc.NYSEHealthcare
$21.68-7.39%ClosedMarket Cap: $692.6M

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

8

Sales

2

Buy/Sell Ratio

4.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Mar 03Etkin Amitdirector, officer: PRESIDENT AND CEOSell6,227$19.691,233,949
Tue Mar 03Smith Nicholas Conradofficer: CHIEF FINANCIAL OFFICER & CBOSell2,806$19.6924,060
Fri Feb 13Etkin Amitdirector, officer: PRESIDENT AND CEOSell306,000$16.71306,000
Fri Feb 13Savitz Adamofficer: CHIEF MEDICAL OFFICERSell124,000$16.71124,000
Fri Feb 13Smith Nicholas Conradofficer: CHIEF FINANCIAL OFFICER & CBOSell200,000$16.71200,000
Fri Feb 13Hanley Jr. Michael Conickofficer: CHIEF OPERATING OFFICERSell131,000$16.71131,000
Tue Jan 06York GwilldirectorSell5,243$16.595,243
Tue Jan 06Cox Christopher NixondirectorSell7,189$16.597,189
Tue Jan 06Manji HusseinidirectorSell4,228$16.594,228
Tue Jan 06Sanchez RamirodirectorSell3,806$16.593,806